|
 |
|
|||||||
|
|||||||||
© 2004 by the American Diabetes Association, Inc.
Pathophysiology/Complications |
Early Glycemic Control, Age at Onset, and Development of Microvascular Complications in Childhood-Onset Type 1 Diabetes
A population-based study in northern Sweden
1 Department of Medicine, Umeå University Hospital, Umeå, Sweden
2 Department of Pediatrics, Umeå University Hospital, Umeå, Sweden
Address correspondence and reprint requests to Dr. Maria Svensson, Department of Medicine, Umeå University Hospital, SE-901 85 Umeå, Sweden. E-mail: maria.svensson{at}medicin.umu.se
OBJECTIVE—The aim of this work was to study the impact of glycemic control (HbA1c) early in disease and age at onset on the occurrence of incipient diabetic nephropathy (MA) and background retinopathy (RP) in childhood-onset type 1 diabetes.
RESEARCH DESIGN AND METHODS—All children, diagnosed at 0–14 years in a geographically defined area in northern Sweden between 1981 and 1992, were identified using the Swedish Childhood Diabetes Registry. From 1981, a nationwide childhood diabetes care program was implemented recommending intensified insulin treatment. HbA1c and urinary albumin excretion were analyzed, and fundus photography was performed regularly. Retrospective data on all 94 patients were retrieved from medical records and laboratory reports.
RESULTS—During the follow-up period, with a mean duration of 12 ± 4 years (range 5–19), 17 patients (18%) developed MA, 45 patients (48%) developed RP, and 52% had either or both complications. A Cox proportional hazard regression, modeling duration to occurrence of MA or RP, showed that glycemic control (reflected by mean HbA1c) during the follow-up was significantly associated with both MA and RP when adjusted for sex, birth weight, age at onset, and tobacco use as potential confounders. Mean HbA1c during the first 5 years of diabetes was a near-significant determinant for development of MA (hazard ratio 1.41, P = 0.083) and a significant determinant of RP (1.32, P = 0.036). The age at onset of diabetes significantly influenced the risk of developing RP (1.11, P = 0.021). Thus, in a Kaplan-Meier analysis, onset of diabetes before the age of 5 years, compared with the age-groups 5–11 and >11 years, showed a longer time to occurrence of RP (P = 0.015), but no clear tendency was seen for MA, perhaps due to lower statistical power.
CONCLUSIONS—Despite modern insulin treatment, >50% of patients with childhood-onset type 1 diabetes developed detectable diabetes complications after 
12 years of diabetes. Inadequate glycemic control, also during the first 5 years of diabetes, seems to accelerate time to occurrence, whereas a young age at onset of diabetes seems to prolong the time to development of microvascular complications.
Abbreviations: AGE, advanced glycation end product • DCCT, Diabetes Control and Complications Trial • MA, incipient diabetic nephropathy (persistent microalbuminuria) • RP, background retinopathy
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Galler, G. Gelbrich, J. Kratzsch, N. Noack, T. Kapellen, and W. Kiess Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study Eur. J. Endocrinol., October 1, 2007; 157(4): 481 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Raile, A. Galler, S. Hofer, A. Herbst, D. Dunstheimer, P. Busch, and R. W. Holl Diabetic Nephropathy in 27,805 Children, Adolescents, and Adults With Type 1 Diabetes: Effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex Diabetes Care, October 1, 2007; 30(10): 2523 - 2528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Cody Infant and toddler diabetes Arch. Dis. Child., August 1, 2007; 92(8): 716 - 719. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mollsten, S. L. Marklund, M. Wessman, M. Svensson, C. Forsblom, M. Parkkonen, K. Brismar, P.-H. Groop, and G. Dahlquist A Functional Polymorphism in the Manganese Superoxide Dismutase Gene and Diabetic Nephropathy Diabetes, January 1, 2007; 56(1): 265 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Stone, M. E. Craig, A. K. Chan, J. W. Lee, C. F. Verge, and K. C. Donaghue Natural History and Risk Factors for Microalbuminuria in Adolescents With Type 1 Diabetes: A longitudinal study. Diabetes Care, September 1, 2006; 29(9): 2072 - 2077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Berhe, D. Postellon, B. Wilson, and R. Stone Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study. Pediatrics, June 1, 2006; 117(6): 2132 - 2137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Svensson, L. Nystrom, S. Schon, G. Dahlquist, and on behalf of the Swedish Childhood Diabetes Study Age at Onset of Childhood-Onset Type 1 Diabetes and the Development of End-Stage Renal Disease: A nationwide population-based study. Diabetes Care, March 1, 2006; 29(3): 538 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Smaldone, J. Honig, P. W. Stone, R. Arons, and K. Weinger Characteristics of California Children With Single Versus Multiple Diabetic Ketoacidosis Hospitalizations (1998-2000) Diabetes Care, August 1, 2005; 28(8): 2082 - 2084. [Full Text] [PDF]
|
|
|
|
|
|
R. Alemzadeh, T. Berhe, and D. T. Wyatt Flexible Insulin Therapy With Glargine Insulin Improved Glycemic Control and Reduced Severe Hypoglycemia Among Preschool-Aged Children With Type 1 Diabetes Mellitus Pediatrics, May 1, 2005; 115(5): 1320 - 1324. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |